Docking to erlotinib off-targets leads to inhibitors of lung cancer cell proliferation with suitable in vitro pharmacokinetics

Liwei Li, Jing Li, May Khanna, Inha Jo, Jason P. Baird, Samy O. Meroueh

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Docking to erlotinib off-targets leads to inhibitors of lung cancer cell proliferation with suitable in vitro pharmacokinetics'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds